Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01275 (
glucagon
)
26,492
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The In-R1-G9 cell line is one of the clones derived from the In-111-R1 hamster insulinoma cell line and produces
glucagon
. The secretory responses of In-R1-G9 cells were further examined to characterize the nature of the cells. Vincristine had no effect on
glucagon
secretion and colchicine enhanced
glucagon
secretion slightly after a short incubation. Two calmodulin inhibitors, trifluoperazine and chlorpromazine, did not affect
glucagon
secretion.
Monensin
at 10(-8) M suppressed
glucagon
secretion by 50%. Secretion of
glucagon
was calcium-dependent. The addition of A23187 to the incubation medium resulted in a 180% increase over control for 1 h and calcium deprivation from the medium suppressed
glucagon
secretion markedly. Theophylline, a phosphodiesterase inhibitor, caused a 230% increase in
glucagon
secretion. An experiment using cycloheximide suggested that newly synthesized
glucagon
appears in the medium at 30 min. This cell line should be useful for various experiments in many fields of research.
...
PMID:Characterization of secretory responses of a glucagon-producing In-R1-G9 cell line. 283 60
These trials explored metabolic events associated with monensin-induced changes in milk composition. In trial 1, diets containing 0 or 33 ppm monensin sodium were fed ad libitum to separate groups of 7 mature lactating goats. In trial 2, diets containing 0 or 18 ppm monensin sodium were fed ad libitum to two groups with 5 mature (greater than 2 yr) and seven young (less than 2 yr) lactating does in each group. Blood was sampled at 1200 h and at 3 min after morning milking in both trials. Diets containing 33 ppm monensin increased serum growth hormone and plasma
glucagon
.
Monensin
(33 ppm) increased growth hormone from 13 to 60 ng/ml in samples taken 3 min after milking.
Monensin
(33 ppm) decreased insulin in these postmilking samples from 432 to 317 pg/ml but increased midday insulin in the samples taken between milkings from 279 to 349 pg/ml.
Monensin
did not affect plasma glucose or serum prolactin concentrations.
Monensin
fed at 18 ppm did not affect growth hormone,
glucagon
, adipose acetyl CoA carboxylase activity, hormone-sensitive lipase, or glucose concentrations. Young animals had higher growth hormone, glucose, and
glucagon
than mature does. The results indicate that effects of milk production intensity can be more important than monensin treatment on milk composition and circulating hormone concentrations.
...
PMID:Effects of feeding monensin to lactating goats: acetyl coenzyme A carboxylase, hormone-sensitive lipase, plasma glucose, and circulating hormones. 288 43